NYSE USD

Becton, Dickinson and Company (BDX)

Compare
221.04 -0.40 (-0.18%)
At close: December 11 at 4:00:02 PM EST
220.15 -0.89 (-0.40%)
After hours: 7:52:17 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
20,178,000.00
20,178,000.00
19,372,000.00
18,870,000.00
19,131,000.00
Cost of Revenue
11,053,000.00
11,053,000.00
11,202,000.00
10,393,000.00
10,500,000.00
Gross Profit
9,125,000.00
9,125,000.00
8,170,000.00
8,477,000.00
8,631,000.00
Operating Expense
6,269,000.00
6,269,000.00
5,746,000.00
6,002,000.00
6,201,000.00
Operating Income
2,856,000.00
2,856,000.00
2,424,000.00
2,475,000.00
2,430,000.00
Net Non Operating Interest Income Expense
-365,000.00
-365,000.00
-403,000.00
-382,000.00
-460,000.00
Other Income Expense
-486,000.00
-486,000.00
-359,000.00
-308,000.00
-277,000.00
Pretax Income
2,005,000.00
2,005,000.00
1,662,000.00
1,783,000.00
1,692,000.00
Tax Provision
300,000.00
300,000.00
132,000.00
148,000.00
88,000.00
Net Income Common Stockholders
1,705,000.00
1,705,000.00
1,424,000.00
1,689,000.00
2,002,000.00
Diluted NI Available to Com Stockholders
1,705,000.00
1,705,000.00
1,424,000.00
1,689,000.00
2,002,000.00
Basic EPS
5.88
5.88
4.97
5.93
6.92
Diluted EPS
5.86
5.86
4.94
5.88
6.85
Basic Average Shares
289,763.00
289,763.00
286,282.00
285,005.00
289,288.00
Diluted Average Shares
291,009.00
291,009.00
288,392.00
287,364.00
292,089.00
Total Operating Income as Reported
2,397,000.00
2,397,000.00
2,111,000.00
2,282,000.00
2,250,000.00
Total Expenses
17,322,000.00
17,322,000.00
16,948,000.00
16,395,000.00
16,701,000.00
Net Income from Continuing & Discontinued Operation
1,705,000.00
1,705,000.00
1,484,000.00
1,779,000.00
2,092,000.00
Normalized Income
2,130,000.00
2,130,000.00
1,854,192.00
1,890,843.00
1,900,724.00
Interest Income
163,000.00
163,000.00
49,000.00
16,000.00
9,000.00
Interest Expense
528,000.00
528,000.00
452,000.00
398,000.00
469,000.00
Net Interest Income
-365,000.00
-365,000.00
-403,000.00
-382,000.00
-460,000.00
EBIT
2,533,000.00
2,533,000.00
2,114,000.00
2,181,000.00
2,161,000.00
EBITDA
4,819,000.00
4,819,000.00
4,402,000.00
4,410,000.00
4,391,000.00
Reconciled Cost of Revenue
11,053,000.00
11,053,000.00
11,202,000.00
10,393,000.00
10,500,000.00
Reconciled Depreciation
2,286,000.00
2,286,000.00
2,288,000.00
2,229,000.00
2,230,000.00
Net Income from Continuing Operation Net Minority Interest
1,705,000.00
1,705,000.00
1,530,000.00
1,635,000.00
1,604,000.00
Total Unusual Items Excluding Goodwill
-500,000.00
-500,000.00
-352,000.00
-279,000.00
-313,000.00
Total Unusual Items
-500,000.00
-500,000.00
-352,000.00
-279,000.00
-313,000.00
Normalized EBITDA
5,319,000.00
5,319,000.00
4,754,000.00
4,689,000.00
4,704,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-75,000.00
-75,000.00
-27,808.00
-23,157.00
-16,276.00
9/30/2021 - 2/21/1973

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BAX Baxter International Inc.
31.00
-1.40%
 
EMBC Embecta Corp.
19.92
-1.43%
 
COO The Cooper Companies, Inc.
99.28
+0.20%
 
RMD ResMed Inc.
245.78
+0.23%
 
WST West Pharmaceutical Services, Inc.
318.22
-0.33%
 
ALC Alcon Inc.
86.57
+0.89%
 
TFX Teleflex Incorporated
183.62
-1.55%
 
ISRG Intuitive Surgical, Inc.
543.60
+1.02%
 
RGEN Repligen Corporation
155.25
+2.18%
 
WRBY Warby Parker Inc.
23.53
0.00%